Clinical Trial Update: NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology

View source ↗

Summary

This completed prospective trial evaluated the diagnostic yield of whole genome sequencing in adults with neurologic disorders. The study was sponsored by Illum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurological Disorders

Snippet

Sponsor: Illumina, Inc. | Conditions: Neurologic Deficits, Neurologic Disorder | Status: COMPLETED